GlaxoSmithKline
About the company
The company profile is sourced from neutral references (Wikipedia, official filings) so this page stays a reference, not an opinion. Our own coverage is in the regulatory history and cases below.
Violations & regulatory history
| Date | Regulator | Type | Fine |
|---|---|---|---|
| Oct 1, 2024 | U.S. state attorneys general / MDL courts | Ranitidine (NDMA) settlements | $2,200,000,000 |
Cases we track
Products & services involved
- Zantac (Ranitidine) (manufacturer)
Frequently asked questions
What cases is GlaxoSmithKline involved in?
We currently track 1 matter involving GlaxoSmithKline: Zantac (Ranitidine NDMA). Each links to the full case record with court, status and settlement information.
What has the regulator found about GlaxoSmithKline?
Our regulatory history table lists 1 recorded item — actions, settlements and penalties with the regulator, date and amount where published. Every row links to its source.
Where does the GlaxoSmithKline information come from?
Company profiles are sourced from neutral references: Wikipedia, official company websites and filings, and regulator records. Our own coverage is the regulatory history table and the case links below.
Affected by GlaxoSmithKline products?
Check the case record and start a free review on the relevant case page: